BP000308-C308: Recombinant Human Monocyte Differentiation Antigen CD14 (CD14) Protein
Source: HEK 293-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000152-CYT-603: Recombinant Human IL-29
Source: E. coli-derived.
Purity > 90%, by SDS-PAGE and RP-HPLC.BP000152-CYT-117: Recombinant Human IL-29, HEK
Source: HEK-derived.
The specific activity was determined by the dose dependent protection of the cytopathic effect on A549 cells (human lung adenocarcinoma epithelial cell line) that were challenged with encephalomyocarditis (EMC) virus and is typically 0.5-5 ug/ml.
Purity: > 95% as obsereved by SDS-PAGE.BP000151-CYT-602: Recombinant Human IL-28A
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000151-CYT-104: Recombinant Human IL-28A, HEK
Source: HEK-derived.
The specific activity was determined by the dose dependent protection of the cytopathic effect on A549 cells (human lung adenocarcinoma epithelial cell line) that were challenged with encephalomyocarditis (EMC) virus and is typically 0.5-5 ug/ml.
Purity: > 95% as obsereved by SDS-PAGE.BP000149-CYT-515: Recombinant Human Interleukin-24 (IL-24) Protein
Source: E. coli-derived.
Measured by its ability to bind to the cell receptor of Capan-1 cells line resulted in Stat-3 activation. The ED50 for this effect is typically 1 ug/ml corresponding to a Specific Activity of 1 MIU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000148-CYT-173: Recombinant Rat Interleukin-22 (IL-22) Protein
Source: E. coli-derived.
The biological activity is measured by its ability to induce IL-10 secretion in COLO 205 (human colon carcinoma cells). The expected ED50 for this effect is 0.15-0.75 ug/ml.
Purity: > 97.0% as determined by RP-HPLC and SDS-PAGE.BP000148-CYT-148: Recombinant Mouse Interleukin-22 (IL-22) Protein
Source: E. coli-derived.
Purity: > 98.0% as determined byGel filtration chromatography under non-denaturing conditions and reducing and non-reducing SDS-PAGE Silver Stained gel. <BP000147-CYT-033: Recombinant Rat IL-21
Source: E. coli-derived.
The biological activity is measured by its ability to proliferate activated B cells.
Purity: > 95.0% as determined by RP-HPLC and SDS-PAGE.BP000147-CYT-684: Recombinant Mouse IL-21
Source: E. coli-derived.
The ED50=10-50 ug/ml, determined by the cell proliferation assay of modified Ba/F3 cells.
Purity > 95%, by SDS-PAGE and RP-HPLC.